CD4 and neoplasm of neck: Given all technical and clinical optimizations in our study design, we did not find a prognostic role for T-cell markers CD3, CD4, CD8, FoxP3, PD1 and the CD8/FoxP3 ratio in the head and neck tumor epithelium, an observation that is in contrast with previous studies [13].